Research  >  Research  >  Labs & groups  >  Neuropsychopharmacology  >  Participate in Research  >  NAB-IT
PAGE
MENU

NAB-IT

Are you or someone you know experiencing agitation associated with Alzheimer’s disease?

We are conducting a new study to examine the safety and efficacy of nabilone for managing agitation in individuals with Alzheimer’s disease.

You may be eligible if you have a diagnosis of Alzheimer’s disease and are experiencing any of these symptoms:

  • Feelings of irritability
  • Restlessness, fidgeting and/or pacing
  • Difficulty cooperating with others
  • Frustration or anger

Participants must have a study partner who is available to participate with them.

For more information, please contact 416-480-6100 x63185 or email memoryresearch@sunnybrook.ca